• A
  • A
  • A
  • ABC
  • ABC
  • ABC
  • А
  • А
  • А
  • А
  • А
Regular version of the site

About the Programme

We invite:

·       Law School graduates interested in healthcare and pharmaceutics

·       Practicing lawyers in the life sciences industry (pharmaceuticals, biotech, medical devices)

·       Regulatory relations specialists

 

We welcome all those who successfully pass the entrance examinations to the program.

 

Program Objectives:

Our program creates a unique platform for professional development for life sciences specialists, focused on continuous growth and the acquisition of new knowledge. We train lawyers and regulatory specialists in the pharmaceutical and biotechnology industries.

First and foremost, we provide a solid theoretical foundation in legal matters. But our theory is always complemented and tested by practice. Therefore, you also gain practical skills in providing legal and regulatory support to companies and institutions in the pharmaceutical and biotechnology sectors.

 

Our program provides the opportunity to master the design, development, optimization, implementation, and application of highly effective regulatory tools, as well as acquire skills in supporting pharmaceutical businesses and biotechnology activities. The program's content is tailored to market needs.

 

Program Benefits:

Among the program's many advantages, we would particularly highlight the following:

 

Advantage No. 1. Mastering unique specializations in dynamically developing industries:

The program offers simultaneous mastery of two unique specializations, the demand for which is steadily and constantly growing in Russia and globally.

Applied focus: The curriculum is designed to address the real-world needs of key players in the pharmaceutical and biotechnology industries, as well as the current agenda of key regulatory bodies and scientific institutions in the pharmaceutical and healthcare industries.

 

Advantage No. 2. Extensive academic opportunities:

Encouragement of master's students' research and expert work: support for participation in Russian and international conferences, roundtables, winter and summer schools; visits to major Russian and international companies and research centers.

Potential scholarships for the best students, including from future employers

in related fields at any HSE faculties.

 

Advantage No. 3. Studying unique courses:

The master's program curriculum includes unique specialized disciplines, including: legal regulation of pharmaceutical industry, legal foundations for the circulation of medical devices, market access: modern strategies and legal mechanisms, legal regulation of intellectual property in the pharmaceutical industry, data protection law in healthcare, legal aspects of compliance, and more.

An integral element of the education is a series of weekly research seminars (RS), conducted in the format of master classes, round tables, business games, etc., with the participation of invited specialists representing leading research organizations, the business community, consulting companies, etc.

 

Advantage No. 4. Theory and practice under the guidance of industry professionals:

The program's academic staff hold advanced degrees in their fields and are widely known for their publications, active expert work, and research.

A significant part of the program professors has unique practical experience working at leading pharmaceutical and biotechnology companies (Abbott, Novartis, Eli Lilly, Sanofi, STADA, AstraZeneca Industries, Agrobiomed, etc.), as well as major consulting firms and legal partnerships (BGP Litigation, Hogan Lovells, etc.).

 

Advantage No. 5. Ongoing interaction with employers:

During their studies, master's students have the opportunity to complete projects commissioned by real industry companies under the guidance and support of program academic staff.

Representatives of the industry's largest employers are involved with master's students at all stages of their studies, including lectures, seminars, projects, and research activities—from the first lectures to the defense of their theses.

 

The program includes two main modules:

"Pharmaceutical Law." This module is devoted to the study of the legal and regulatory frameworks of the pharmaceutical industry, including the most relevant aspects, emerging case law, and global trends in the development of legal regulation in this area.

 

"Medical Law." This module focuses on the legal framework of medical practice and the current legal and ethical aspects of digitalization in healthcare, as well as the acquisition of practical skills for supporting the work of a health care organization.